irinotecan mylan 40mg/2ml vial
ارينوتيكان ميلان 40 مجم / 2 مل فيال
irinotecanThe published official price. Pharmacies may differ slightly.
- Strength
- 40mg/2ml
- Form
- vial
- Manufacturer
- hospira inc.-uk > pfizer scientific office
- Route
- injection
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Uses
Used in the treatment of metastatic colorectal cancer, either alone or in combination chemotherapy regimens.
Do not use if
Contraindicated in patients with hypersensitivity to irinotecan or formulation components.
Side effects
May cause severe diarrhea, neutropenia, nausea, vomiting, alopecia, anemia, and fatigue.
Warnings
Severe diarrhea and myelosuppression may be life-threatening and require close monitoring.
How it works
Irinotecan is a topoisomerase I inhibitor whose active metabolite interferes with DNA replication in cancer cells.
Storage
Store at 20–25°C and protect from light.